Order Article Reprints

Marchetti M, Gomez-Rosas P, Russo L, Tartari CJ, Bolognini S, Ticozzi C, Romeo D, Schieppati F, Barcella L, Sarmiento R, et al. Baseline Hemostatic Biomarker Assessment Identifies Breast Cancer Patients at High Risk for Venous Thromboembolism During Chemotherapy. Cancers. 2025; 17(16):2712. https://doi.org/10.3390/cancers17162712

Marchetti, Marina, Patricia Gomez-Rosas, Laura Russo, Carmen Julia Tartari, Silvia Bolognini, Chiara Ticozzi, Debora Romeo, Francesca Schieppati, Luca Barcella, Roberta Sarmiento, and et al. 2025. "Baseline Hemostatic Biomarker Assessment Identifies Breast Cancer Patients at High Risk for Venous Thromboembolism During Chemotherapy" Cancers 17, no. 16: 2712. https://doi.org/10.3390/cancers17162712

Marchetti, M., Gomez-Rosas, P., Russo, L., Tartari, C. J., Bolognini, S., Ticozzi, C., Romeo, D., Schieppati, F., Barcella, L., Sarmiento, R., Masci, G., Gasparini, G., De Braud, F., Tondini, C., Santoro, A., Petrelli, F., Giuliani, F., D’Alessio, A., Labianca, R., & Falanga, A., on behalf of the HYPERCAN Investigators. (2025). Baseline Hemostatic Biomarker Assessment Identifies Breast Cancer Patients at High Risk for Venous Thromboembolism During Chemotherapy. Cancers, 17(16), 2712. https://doi.org/10.3390/cancers17162712